GALWAY, Ireland–(BUSINESS WIRE)–WhiteSwell, a company pioneering new ways to treat acute decompensated heart failure, today announced the close of a $30 million series B funding round led by RA Capital Management and an InCube Ventures syndicate, with participation from other investors. Funds from the round will be used to support […]
Financial
Avinger Announces Successful Treatment of 500th Patient with Next-Generation Pantheris Device
REDWOOD CITY, Calif., Dec. 13, 2018 (GLOBE NEWSWIRE) — Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that physicians in 59 sites globally have successfully treated more than 500 patients with the next-generation Pantheris image-guided atherectomy system for the treatment of […]
5 Top Mergers and Acquisitions in MedTech/Biotech for 2018
by Ken Dropiewski, Principal Consultant – McDermott &Bull Executive Search 5 Top Mergers and Acquisitions in MedTech/Biotech for 2018 Who and Why? I started researching top M&A activity this year and came across multiple deals that were interesting regardless of their size. Some were headscratchers, but others seemed to make tremendous […]
Otsuka Medical Devices and Veryan Medical Announce Completion of Acquisition
TOKYO, Japan and HORSHAM, U.K., 13 December, 2018 — Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”), a 100% subsidiary of Otsuka Holdings Co., Ltd., and Veryan Medical Ltd. (“Veryan”) announce the completion of the acquisition of Veryan by Otsuka Medical Devices through its UK subsidiary Otsuka Medical Devices UK […]
Merit Medical Ireland Wins Medtech Company of the Year Award 2018
SOUTH JORDAN, Utah, Dec. 10, 2018 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, today announced that its subsidiary Merit Medical Ireland won the […]
XyloCor Therapeutics Raises $17 Million in Series A Financing to Advance Gene Therapy Portfolio in Cardiovascular Disease
PHILADELPHIA–(BUSINESS WIRE)–XyloCor Therapeutics, a private clinical-stage biopharmaceutical company focused on the development of gene therapy for unmet needs in cardiovascular disease, today announced the close of a $17 million Series A financing which was co-led by Sofinnova Ventures and LSP (Life Sciences Partners). Proceeds from the financing will be used […]
MyoKardia to Present at the BMO 2018 Prescriptions for Success Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Dec. 05, 2018 (GLOBE NEWSWIRE) — MyoKardia, Inc. (Nasdaq: MYOK), a clinical-stage biopharmaceutical company pioneering precision medicine for the treatment of cardiovascular diseases, today announced that Taylor Harris, Chief Financial Officer, will present at the BMO 2018 Prescriptions for Success Healthcare Conference on Wednesday, December 12, 2018, […]
P. (Laxmin) Laxminarain Appointed to Millar’s Board of Directors
HOUSTON, Dec. 5, 2018 /PRNewswire/ — Millar, Inc., medical device manufacturer and OEM pressure sensor integration partner, today announced the appointment of P. (Laxmin) Laxminarain to the company’s Board of Directors. Mr. Laxminarain’s successful track record in the medical device industry for over 30 years will provide Millar a significant upgrade in governance talent […]
MEDTRONIC STATEMENT REGARDING RECENT DOJ ANNOUNCEMENT
DUBLIN – December 4, 2018 – Medtronic plc has agreed with the United States Department of Justice (DOJ) to resolve three claims against Covidien LP and ev3, Inc., now part of Medtronic. Regarding a matter concerning the Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry, […]
Orchestra BioMed™ Appoints C. Evan Ballantyne as Chief Financial Officer
NEW HOPE, Pa., Dec. 04, 2018 (GLOBE NEWSWIRE) — Orchestra BioMed, Inc. (“Orchestra BioMed” or the “Company”), a biomedical innovation company developing advanced therapeutic solutions to address major unmet medical needs, announced today that it has appointed Evan Ballantyne as its Chief Financial Officer (CFO). Mr. Ballantyne is an experienced financial and […]
Recent
JenaValve Appoints Maria Jose Arana as Vice President of Quality and Compliance
RadNet Announces a Proposed $200 Million Incremental Term Loan to Fund Strategic Growth Opportunities
Medtronic announces strategic investments to support future expansion of cardiac ablation portfolio as physician demand for Affera™ technologies broadens
Popular
- No commented posts yet